Effect of insulin resistance on left ventricular hypertrophy and dysfunction in essential hypertension

Journal of Hypertension

Volumn 17, Issue 8, 1999, Pages 1153-1160

  Watanabe, Kouki ^a   Sekiya, Michihito ^b   Tsuruoka, Takashi ^a   Funada, Jun Ichi ^b   Kameoka, Hiroshi ^a  

^a Minamiuwa Ehime Pref Hospital   (Japan)

^b National Hospital Organization Ehime Medical Center   (Japan)

Author keywords

Angiotensin converting enzyme inhibitor; Diastolic function; Hypertension; Hypertrophy; Insulin resistance

Indexed keywords

GLUCOSE; INSULIN; TEMOCAPRIL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DIASTOLE; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEART DISEASE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; SYSTOLIC BLOOD PRESSURE;

EID: 0032784935     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199917080-00015     Document Type: Article

References (44)

1. 1 Kannel WB, Castelli WP, McNamara PM, McKee PA, Feinleib M. Role of blood pressure in the development of congestive heart failure: the Framingham study. N Engl J Med 1972; 287:781-787.
2. 2 Levy D, Garrison RJ, Savage DD, Kannek WB, Castelli WP. Left ventricular mass and incidence of coronary heart disease in an elderly cohort: The Framingham Study. Ann Intern Med 1989; 110:101-108.
3. 3 Fouad FM, Tarazi RC, Gallagher JH, MacIntyre WJ, Cook SA. Abnormal left ventricular relaxation in hypertensive patients. Clin Sci 1980; 59:411S-414S.
4. 4 Iriate M, Murga N, Sagastagoitia D, Moriallas M, Boveda J, Aierbe P. Classification of hypertensive cardiomyopathy. Eur Heart J 1993; 14:95-101.
5. 5 Swislocki ALM, Huffman BB, Reaven GM. Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension. Am J Hypertens 1989; 49:419-423.
6. 6 Regan TJ, Wu CF, Yen CK, Oldewurte HA, Haider. Myocardial composition and function in diabetes: the effect of chronic insulin use. Circ Res 1981; 49:1268-1277.
7. 7 Nagano N, Nagano M, Yo Y, Iijima K, Higaki J, Mikami H, et al. Role of glucose intolerance in cardiac diastolic function in essential hypertension. Hypertension 1994; 23:1002-1005.
8. 8 Nakamura NH, Kohara K, Sumimoto T, Lin M, Hiwada K. Glucose intolerance exaggerates left ventricular hypertrophy and dysfunction in essential hypertension. Am J Hypertens 1994; 7:1110-1114.
9. 9 Jain A, Avendano G, Dharamsey S, Dasmahaparta A, Agarwal R, Reddi A, et al. Left ventricular diastolic function in hypertension and role of plasma glucose and insulin: comparison with diabetic heart. Circulation 1996; 33:1396-1402.
10. 10 Paolisso G, Galzerano D, Gambardolla A, Varricchio G, Saccomanno F, D'Amore A, et al. Left ventricular hypertrophy is associated with a stronger impairment of non-oxidative glucose metabolism in hypertensive patients. Eur J Clin Invest 1995; 25:529-533.
11. 11 Lind L, Anderson PE, Andrén B, Hänni A, Lithell HO. Left ventricular hypertrophy in hypertension is associated with the insulin resistance metabolic syndrome. J Hypertens 1995; 13:433-438.
12. 12 Miyagawa M, Kumano S, Sekiya M, Watanabe K, Akutsu H, Imachi T, et al. Thallium-201 myocardial tomography with intravenous infusion of adenosine triphosphate in diagnosis of coronary artery disease. J Am Coll Cardiol 1995; 26:1196-1201.
13. 13 Watanabe K, Sekiya M, Ikeda S, Miyagawa M, Kinoshita M, Kumano S. Comparison of adenosine triphosphate and dipyridamole in diagnosis by thallium-201 myocardial scintigraphy. J Nucl Med 1997; 38:577-581.
14. 14 Shen SW, Reaven GM, Farquhar J. Comparison of impedence to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. J Clin Invest 1970; 49:2151-2160.
15. 15 Harano Y, Hidaka H, Takatsuki K, Ohgaku S, Haneda M, Motoi S, et al. Glucose, insulin, and somatostatin infusion for the determination of insulin sensitivity in vivo. Metabolism 1978; 27 (suppl 1):1449-1452.
16. 16 WHO study group. Definition, diagnosis, and classification: diabetes mellitus. Technical Report Series 727. Geneva: World Health Organization; 1985. pp. 9-25.
17. 17 Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendation regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58:1072-1083.
18. 18 Quinones MA, Pikerring E, Alexander JK. Percentage of shortening of the echocardiographic left ventricular dimension. Its use in determining ejection fraction and stroke volume. Chest 1978; 78:59-63.
19. 19 Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977; 55:613-618.
20. 20 Galderisi M, Anderson KM, Wilson PWF, Levy D. Echocardiographic evidence of a distinct diabetic cardiomyopathy: the Framingham Heart Study. Am J Cardiol 1991; 68:85-89.
21. 21 Scherror U, Randin D, Tappy L, Vollenweider P, Jequier E, Nicod P. Body fat and sympathetic nerve activity in healthy subjects. Circulation 1994; 89:2634-2640.
22. 22 DeFronzo RA, Cooke CR, Andres R, Faloona GR, Davis PJ. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest 1975; 55:845-855.
23. 23 Hall JE. Hyperinsulinemia: a link between obesity and hypertension? Kidney Int 1993; 43:1402-1417.
24. 24 Rowe JW, Young JB, Miwaker KL, Stevens AL, Palotta J, Landsberg L. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 1981; 30:219-225.
25. 25 Stout RW, Bierman EL, Ross R. Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells Circ Res 1975; 36:319-327.
26. 26 Tuck ML. Obesity, the sympathetic nervous system, and essential hypertension Hypertension 1992; 19 (suppl 1):1-37-77.
27. 27 Smith U. Insulin resistance in hypertension. In: Moler DE (editors): Insulin resistance. Chichester, John Wiley & Sons; 1993. pp. 1-8.
28. 28 Dahlof B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies Am J Hypertens 1992; 5:95-110.
29. 29 Donnelly R. Angiotensin-converting enzyme inhibitors and insulin sensitivity: metabolic effects in hypertension, diabetes and heart failure J Cardiovasc Pharm 1992; 20 (suppl 11):59-64.
30. 30 Rett K, Jauch KW, Wicklmayr M, Dietze G, Fink E, Mehnert H. Angiotensin converting enzyme inhibitors in diabetes: experimental and human experience Postgrad Med J 1986; 62 (suppl 1);59-64.
31. 31 Andersson PE, Lind L, Andren B, Hanni A, Reneland R, Christian B, et al. Regression of left ventricualr wall thickness during ace-inhibitor treatment of essential hypertension is associated with an increase in insulin mediated skeletal muscle blood flow. Blood Press 1998; 7:118-126.
32. 32 Griendling K, Ollerenshaw JD, Minieri CA, Alexander RW. Angiotensin II stimulates NADH and NADPH activity in cultured vascular smooth muscle cells Circ Res 1994; 74:1141-1148.
33. 33 Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman BA, Griendling KK, et al. Angiotensin II mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone J Clin Invest 1996; 97:1916-1923.
34. 34 Genovesi-Evert A, Marabotti C, Palombo C, Giaconi S, Ghione S. Different determinants of left ventricular filling in normotensive subjects and essential hypertensive patients Am J Hypertens 1989; 2:117-119.
35. 35 Douglas P, Tallant B. Hypertrophy, fibrosis and diastolic dysfunction in early canine experimental hypertension J Am Coll Cardiol 1991; 17:530-536.
36. 36 Berne C, Pollare T, Lithell H. Effects of antihypertensive treatnt on insulin sensitivity with special reference to ACE inhibitors Diabetes Care 1991; 14:39-47.
37. 37 Paolisso G, Gambardella A, Verza M, D' Amore A, Sgambato S, Varricchio M. ACE inhibition improves insulin sensitivity in aged insulin resistant hypertensive patients. J Hum Hypertens 1992; 6:175-179.
38. 38 Iwatsubo H, Nagano M, Sakai T, Kumamoto K, Morita R, Higaki J, et al. Converting enzyme inhibitor improves forearm reactive hyperemia in essential hypertension. Hypertension 1997; 29:286-290.
39. 39 Weinberg EO, Schoen FJ, George D, Kagaya Y, Douglas P, Litwin SE, et al. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. Circulation 1994; 90:1410-1422.
40. 40 Vogt M, Motz W, Po Litz B, Scheler S, Strauer BE. Improvement of coronary reserve by chronic treatment with ACE inhibitors. Circulation 1991; 84 (suppl 2):541-546.
41. 41 Rakugi H, Kim DK, Krieger JE, Wang DS, Dzau VJ, Pratt RE. Induction of angiotensin converting enzyme in the neointima after vascular injury: possible role in restenosis. J Clin Invest 1994; 93:339-346.
42. 42 Nagano M, Higaki J, Nakamura F, Higashimori K, Nagano N, Mikami H, et al. Role of cardiac angiotensin II in isoproterenol-induced left ventricular hypertrophy. Hypertension 1992; 19:708-712.
43. 43 Mizuno K, Niimura S, Tani M, Haga H, Inagami T, Fukuchii S. Direct proof for local generation and release of angiotensin II in peripheral human vascular tissue. Am J Hypertens 1991; 4:67-72.
44. 44 Morishita R, Higaki J, Miyazaki M, Ogihara T. Possible role of the vascular renin-angiotensin system in hypertension and vascular hypertrophy. Hypertension 1992; 19 (suppl 2):62-67.